Therefore, the enrichment of H3K27me3 at the HDAC7 promoter prompted us to investigate whether EZH2 may be responsible for its silencing in t(4;11) pro-B-ALL cells. Here, HDAC7 is linked to acute lymphoblastic leukemia.